Gujarat Inject Kerala Ltd
Gujarat Inject Kerala Ltd (GUJINJEC) last reported results for the quarter ended Jun 2026, with sales of ₹12.45 crore and net profit of ₹1.25 crore. The stock last traded at ₹9.36, a market capitalisation of ₹137 crore, on a P/E of 45.7. Over the past 52 weeks the stock has ranged between ₹1.96 and ₹14.3. Figures are as of 6 Oct 2026 and are not real time.
Gujarat Inject Kerala Ltd share price and key metrics
- Current price
- ₹9.36
- Market cap
- ₹137 cr
- Stock P/E
- 45.7
- Book value
- ₹0.81
- ROE
- 16.6%
- ROCE
- 22.9%
- Dividend yield
- 0.00%
- 52w high / low
- 14.3/1.96
Metrics as of 6 Oct 2026. Not real time.
Track Gujarat Inject Kerala Ltd
Cruxal reads every Gujarat Inject Kerala Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Gujarat Inject Kerala Ltd growth and returns
- 10 Years
- 112%
- 5 Years
- 415%
- 3 Years
- 498%
- TTM
- 152%
- 10 Years
- %
- 5 Years
- 79%
- 3 Years
- 256%
- TTM
- 213%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 109%
- 1 Year
- 355%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 12%
- Last Year
- 17%
Gujarat Inject Kerala Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹12.45 cr, up 414.5% from ₹2.42 cr a year earlier. Net profit was ₹1.25 cr, up 1685.7% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 8.61 | 3.15 | 4.24 | 2.42 | 1.58 | 1.63 | 30.7 | 12.45 |
| Expenses | 8.07 | 2.87 | 4.15 | 2.32 | 1.55 | 1.72 | 28.43 | 10.76 |
| Operating profit | 0.54 | 0.28 | 0.09 | 0.1 | 0.03 | -0.09 | 2.27 | 1.69 |
| OPM % | 6.27% | 8.89% | 2.12% | 4.13% | 1.90% | -5.52% | 7.39% | 13.57% |
| Other income | 0.17 | 0 | 0.01 | 0 | 0.06 | 0.14 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0.71 | 0.28 | 0.1 | 0.1 | 0.09 | 0.05 | 2.27 | 1.69 |
| Tax % | 14.08% | 25.00% | 30.00% | 20.00% | 22.22% | 20.00% | 27.75% | 26.04% |
| Net profit | 0.61 | 0.21 | 0.07 | 0.07 | 0.07 | 0.04 | 1.64 | 1.25 |
| EPS (₹) | 0.04 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.09 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Gujarat Inject Kerala Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.57 | 0 | 0 | 0 | 0.01 | 0.02 | 0.17 | 5.79 | 19.05 | 36.32 | 46.36 |
| Operating profit | 0.01 | -0.07 | -0.03 | -0.01 | -0.12 | -0.05 | -0.37 | 0.05 | 1.07 | 2.3 | 3.9 |
| OPM % | 0.64% | — | — | — | -1,200.00% | -250.00% | -217.65% | 0.86% | 5.62% | 6.33% | 8.41% |
| Net profit | 0.01 | -0.02 | -0.01 | 0 | -0.11 | 0 | 0.04 | 0.08 | 1.02 | 1.81 | 3 |
| EPS (₹) | 0.00 | -0.00 | -0.00 | 0.00 | -0.02 | 0.00 | 0.01 | 0.01 | 0.07 | 0.12 | 0.20 |
TTM is the trailing twelve months to the most recent quarter.
Gujarat Inject Kerala Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 4.88 | 11.29 | 14.63 | 14.63 |
| Reserves | -5.64 | -5.66 | -5.66 | -5.66 | -5.77 | -5.76 | -5.72 | -2.75 | -4.62 | -2.81 |
| Borrowings | 0.57 | 0.59 | 0.59 | 0.59 | 0.69 | 0.73 | 0.61 | 0.00 | 0.00 | 0.00 |
| Other liabilities | 0.20 | 0.21 | 0.20 | 0.20 | 0.22 | 0.22 | 0.53 | 0.15 | 1.94 | 24.85 |
| Total liabilities | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.07 | 0.30 | 8.69 | 11.95 | 36.67 |
| Fixed assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 20.76 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.07 | 0.30 | 8.69 | 11.95 | 15.91 |
| Total assets | 0.01 | 0.02 | 0.01 | 0.01 | 0.02 | 0.07 | 0.30 | 8.69 | 11.95 | 36.67 |
As reported by the company. Total assets equal total liabilities by construction.
Gujarat Inject Kerala Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 0.00 | -0.01 | 0.00 | 0.00 | -0.11 | 0.00 | 0.05 | -6.03 | -3.52 | 21.22 |
| Cash from investing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.18 | -20.57 |
| Cash from financing | 0.00 | 0.00 | 0.00 | 0.00 | 0.10 | 0.00 | 0.00 | 8.88 | 0.45 | 0.00 |
| Net cash flow | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 2.86 | -2.89 | 0.65 |
| Free cash flow | 0.00 | -0.01 | 0.00 | 0.00 | -0.11 | 0.00 | 0.05 | -6.03 | -3.52 | 0.46 |
| CFO / operating profit | 0% | 14% | 0% | 0% | 92% | 0% | -16% | -12,020% | -307% | 953% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Gujarat Inject Kerala Ltd operating ratios
| Per year | Mar 2017 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| ROCE % | — | — | — | — | 2.65% | 13.48% | 22.90% |
| Debtor days | 0.00 | 0.00 | 0.00 | 0.00 | 187.86 | 137.57 | 63.81 |
| Inventory days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash conversion cycle | 0.00 | 0.00 | 0.00 | 0.00 | 187.86 | 137.57 | 63.81 |
| Working capital days | -106.94 | -17,520.00 | -9,490.00 | -1,545.88 | 354.91 | 137.76 | -140.29 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Gujarat Inject Kerala Ltd shareholding pattern
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Public | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.01% | 100.00% |
| No. of shareholders | 6,627 | 6,773 | 7,303 | 7,303 | 8,151 | 7,826 | 7,853 | 8,038 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Gujarat Inject Kerala Ltd corporate filings
- Gujarat Inject Kerala Ltd releases corporate update via press releaseCompany Updatelow impact
Cruxal's analysis: The company, with a market cap of approximately 141.66 crore, has issued a regulatory…
Read the full analysis - Gujarat Inject Kerala Limited secures a purchase order worth approximately ₹4.86 crore for 3,600 solar PV modules, indicating a strategic move into solar infrastructure.Company Updatehigh impact
Cruxal's analysis: Gujarat Inject Kerala Limited has received a purchase order from Zentaraa Infra Projects…
Read the full analysis - Corporate Voting Results Confirm Requisite Majorities for All Resolutions at Gujarat Inject Kerala Limited's 35th AGMAGM/EGMmedium impact
Cruxal's analysis: Gujarat Inject Kerala Limited's 35th AGM, held on 29th September 2026, saw all…
Read the full analysis - Gujarat Inject Kerala Ltd holds 35th AGM; no immediate financial disclosures or strategic updates announcedAGM/EGMlow impact
Cruxal's analysis: Gujarat Inject Kerala Ltd conducted its 35th Annual General Meeting on 29th September…
Read the full analysis - Gujarat Inject Kerala Limited Initiates Shareholder Process for Post-Split Demat CreditCompany Updatelow impact
Cruxal's analysis: Gujarat Inject Kerala Limited has issued a formal intimation to shareholders regarding…
Read the full analysis - Closure of Trading Window for 2nd Quarter and Half Year Ended on 30th, September, 2026Insider Trading / SASTlow impact
- Gujarat Inject (Kerala) Limited Announces Change in Statutory AuditorCompany Updatelow impact
Cruxal's analysis: Gujarat Inject (Kerala) Limited has announced the appointment of M/s. S N D K &…
Read the full analysis - Gujarat Inject Kerala Ltd releases Annual Report for FY 2025-26Otherslow impact
Cruxal's analysis: Gujarat Inject Kerala Ltd has filed its Annual Report for the financial year 2025-26 as…
Read the full analysis - Gujarat Inject (Kerala) Limited Announces 35th AGM and Board AppointmentsAGM/EGMhigh impact
Cruxal's analysis: Gujarat Inject (Kerala) Limited has issued the notice for its 35th Annual General Meeting…
Read the full analysis - Gujarat Inject Kerala Ltd releases Q2 2026-2027 press noteCompany Updatelow impact
Cruxal's analysis: Gujarat Inject Kerala Ltd has issued a press note regarding its financial performance for…
Read the full analysis - Gujarat Inject Kerala Ltd enters into a Strategic Business Partnership AgreementCompany Updatelow impact
Cruxal's analysis: The company has announced the execution of a Strategic Business Partnership Agreement…
Read the full analysis - Gujarat Inject Kerala Ltd shareholders approve company name change to Regenova Renewtech LimitedAGM/EGMlow impact
Cruxal's analysis: Gujarat Inject Kerala Ltd has concluded its adjourned Extraordinary General Meeting (EGM)…
Read the full analysis - Gujarat Inject Kerala Limited Proposes Name Change to Regenova Renewtech LimitedAGM/EGMlow impact
Cruxal's analysis: Gujarat Inject Kerala Limited has conducted an adjourned Extra Ordinary General Meeting…
Read the full analysis - Gujarat Inject Kerala Limited adjourns EGM due to lack of quorumAGM/EGMlow impact
Cruxal's analysis: Gujarat Inject Kerala Limited has announced the adjournment of its 01/2026-27 Extra…
Read the full analysis - Gujarat Inject (Kerala) Limited appoints Radadiya HardikKumar AnilBhai as Chief Financial OfficerCompany Updatelow impact
Cruxal's analysis: Gujarat Inject (Kerala) Limited has announced the appointment of Mr. Radadiya HardikKumar…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.